Artículo

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

Neukam, Karin; Almeida, Carmen; Caruz, Antonio; Rivero Juarez, Antonio; Rallon, Norma; Di Lello, Federico AlejandroIcon ; Herrero, Rocío; Camacho, Angela; Benito, José; Macias, Juan; Rivero, Antonio; Soriano, Vicente; Pineda, Juan Antonio
Fecha de publicación: 12/12/2012
Editorial: Oxford University Press
Revista: Journal of Antimicrobial Chemotherapy
ISSN: 0305-7453
Idioma: Inglés
Tipo de recurso: Artículo publicado

Resumen

Accurate prediction of sustained virological response (SVR) to pegylated interferon-a (Peg-IFN) plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients could improve the management of these patients. We aimed to develop a model to predict SVR to Peg-IFN/ribavirin in HIV/HCV-coinfected individuals combining HCV genotype and baseline HCV RNA load with interleukin 28B and low-density lipoprotein receptor genetic variations.

Archivos asociados

Documento no disponible
Tamaño: 298.7Kb
Formato: PDF
http://jac.oxfordjournals.org/content/early/2012/12/12/jac.dks488
http://jac.oxfordjournals.org/content/68/4/915.full.pdf+html
http://jac.oxfordjournals.org/content/early/2012/12/18/jac.dks488
http://dx.doi.org/doi:10.1093/jac/dks488
info:eu-repo/semantics/restrictedAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Citación: Neukam, Karin; Almeida, Carmen; Caruz, Antonio; Rivero Juarez, Antonio; Rallon, Norma; et al.; A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients; Oxford University Press; Journal of Antimicrobial Chemotherapy; 68; 4; 12-12-2012; 915-921
URI: http://hdl.handle.net/11336/1998
 

Comunidades y colecciones